311 related articles for article (PubMed ID: 17020459)
1. Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs.
Jones RL; Ewer MS
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1249-69. PubMed ID: 17020459
[TBL] [Abstract][Full Text] [Related]
2. Cardiac toxicity: old and new issues in anti-cancer drugs.
Sereno M; Brunello A; Chiappori A; Barriuso J; Casado E; Belda C; de Castro J; Feliu J; González-Barón M
Clin Transl Oncol; 2008 Jan; 10(1):35-46. PubMed ID: 18208791
[TBL] [Abstract][Full Text] [Related]
3. Anticancer agents and cardiotoxicity.
Ng R; Better N; Green MD
Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642
[TBL] [Abstract][Full Text] [Related]
4. Prevention and management of cardiotoxicity from antineoplastic therapy.
Chanan-Khan A; Srinivasan S; Czuczman MS
J Support Oncol; 2004; 2(3):251-6; discussion 259-61, 264-6. PubMed ID: 15328825
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
Yeh ET; Tong AT; Lenihan DJ; Yusuf SW; Swafford J; Champion C; Durand JB; Gibbs H; Zafarmand AA; Ewer MS
Circulation; 2004 Jun; 109(25):3122-31. PubMed ID: 15226229
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological foundations of cardio-oncology.
Minotti G; Salvatorelli E; Menna P
J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
[TBL] [Abstract][Full Text] [Related]
7. [Cardiotoxicity of antineoplastic drugs].
Drzewoski J; Kasznicki J
Acta Haematol Pol; 1992; 23(2):79-86. PubMed ID: 1488864
[TBL] [Abstract][Full Text] [Related]
8. Anthracycline cardiotoxicity in childhood.
Ruggiero A; Ridola V; Puma N; Molinari F; Coccia P; De Rosa G; Riccardi R
Pediatr Hematol Oncol; 2008 Jun; 25(4):261-81. PubMed ID: 18484471
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity of cancer therapy.
Floyd JD; Nguyen DT; Lobins RL; Bashir Q; Doll DC; Perry MC
J Clin Oncol; 2005 Oct; 23(30):7685-96. PubMed ID: 16234530
[TBL] [Abstract][Full Text] [Related]
10. [Cardiotoxicity of antracycline treatment in the light of new biochemical diagnostic options].
Urbanová D; Mladosievicová B
Vnitr Lek; 2007 Jun; 53(6):669-77. PubMed ID: 17702127
[TBL] [Abstract][Full Text] [Related]
11. State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: a literature review.
Berardi R; Caramanti M; Savini A; Chiorrini S; Pierantoni C; Onofri A; Ballatore Z; De Lisa M; Mazzanti P; Cascinu S
Crit Rev Oncol Hematol; 2013 Oct; 88(1):75-86. PubMed ID: 23522920
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of systemic cancer treatment.
Senkus E; Jassem J
Cancer Treat Rev; 2011 Jun; 37(4):300-11. PubMed ID: 21126826
[TBL] [Abstract][Full Text] [Related]
13. Anthracycline cardiotoxicity.
Menna P; Paz OG; Chello M; Covino E; Salvatorelli E; Minotti G
Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S21-36. PubMed ID: 21635149
[TBL] [Abstract][Full Text] [Related]
14. [Cardiotoxicity of drugs used in oncology].
Poprach A; Petráková K; Vyskocil J; Lakomý R; Nemecek R; Kocák I; Kocáková I; Vyzula R
Klin Onkol; 2008; 21(5):288-93. PubMed ID: 19202960
[TBL] [Abstract][Full Text] [Related]
15. Anthracycline-induced cardiotoxicity in adult hematologic malignancies.
Johnson SA
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S22-7. PubMed ID: 16781286
[TBL] [Abstract][Full Text] [Related]
16. [Antileukemic].
Inomata T; Sunami K
Nihon Rinsho; 2015 Feb; 73 Suppl 2():191-4. PubMed ID: 25831750
[No Abstract] [Full Text] [Related]
17. [Cardiovascular toxicity of some cancer agents (others than anthracyclines, fluoropyrimidines and trastuzumab)].
Saintigny P; Chouahnia K; Charniot JC; Breau JL
Bull Cancer; 2004 Nov; 91 Suppl 3():174-84. PubMed ID: 15899625
[TBL] [Abstract][Full Text] [Related]
18. Predicting and preventing the cardiotoxicity of cancer therapy.
Anderson B; Sawyer DB
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1023-33. PubMed ID: 18666852
[TBL] [Abstract][Full Text] [Related]
19. Cancer drugs and the heart: importance and management.
Suter TM; Ewer MS
Eur Heart J; 2013 Apr; 34(15):1102-11. PubMed ID: 22789916
[TBL] [Abstract][Full Text] [Related]
20. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.
Minotti G; Menna P; Salvatorelli E; Cairo G; Gianni L
Pharmacol Rev; 2004 Jun; 56(2):185-229. PubMed ID: 15169927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
